Cell and gene therapy

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Cell and gene therapy market: Hear from the experts

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

CAR-T therapy
#CAR-T #Cell and gene therapy #Cell therapy #Immunotherapy #Kyverna Therapeutics #Oncology

Novel CAR T-cell vein-to-vein process could reduce time and cost

A paper in BioRxiv has described a new process that could improve the chimeric antigen receptor (CAR) T-cell patient experience and reduce costs through a minimisation of the CAR T-cell therapy vein-to-vein process. The process utilises less than 300ml of whole blood from a blood draw… Read More

#Cancer Research #News

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Register now: Cell and gene therapy opportunities webinar

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

Miami skyline
#Advanced Therapies #Cell and gene therapy #Drug development #Manufacturing #Viral vectors

What challenges does the advanced therapies sector face? 

Over the three days of Advanced Therapies Week (ATW) 2024 in Miami, Florida, US, 16-19 January 2024, DDW’s Megan Thomas heard from attendees about the obstacles the sector needs to overcome to succeed.   Viral vector manufacturing   At the Advanced Therapies Awards ceremony, Dr Luigi Naldini, Director of the San Raffaele… Read More

#Exclusive Content #Opinion #Regulatory

UK
#Advanced Therapies #BioIndustry Association #Cell and gene therapy #Cell and Gene Therapy Catapult #UK

UK maintains dominant global position in cell and gene therapy

The UK is cementing its position as a global leader in cell and gene therapy (CGT), according to a new report released today by the UK BioIndustry Association (BIA), in collaboration with Citeline. The report reveals a robust sector with significant investment, the highest number of… Read More

#News #Trending News

European map
#Advanced Therapies Europe #Biologics / Biotechnology #Cancer immunotherapy #CAR-T #Cell and gene therapy #Cell therapy #Collaboration #Europe #Immuno-oncology #Market reporting #Oncology #Start-ups

New podcast: Why is Europe a drug discovery epicentre?

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: European drug discovery and development success stories,… Read More

#News

Cell and gene therapy
#Adverse event #Blood cancer #CAR-T #Cell and gene therapy #Cell therapy #FDA #Immunotherapy #ISCT #Oncology

Experts comment on FDA report on risk of T-cell malignancy  

The International Society for Cell & Gene Therapy (ISCT) has announced the publication in Nature Medicine of an expert consortium commentary addressing a recent statement from the US Food & Drug Administration (FDA) that it is investigating serious risk of T-cell malignancy in patients who received treatment with BCMA- or… Read More

#News #Regulatory

Human cell
#Biologics #Cell and gene therapy #Cytomos #Lab technology #Single-cell analysis

Can cell analysis tech help streamline biotech product development?

Scotland-based biotech Cytomos has launched its newly patented AuraCyt cell analysis technology brand. According to the company, AuraCyt provides information on cell properties and can be incorporated in-line, allowing real-time monitoring of cell manufacturing events and predicting manufacturing success. It is designed to collect data that measures the intrinsic properties… Read More

#Business & Investment #News

Woman reading on a tablet
#2023 #Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Biotech hubs #Cell and gene therapy #CRISPR #Diversity #Oncology #Regulatory

DDW top reads in 2023

DDW’s Senior Digital Content Editor Diana Spencer reviews the year’s top ten articles. DDW’s top 10 most popular articles for 2023 reflect the key subjects in drug discovery and development. In a record year for gene therapy approvals, it isn’t surprising that cell & gene therapy (CGT) has been a… Read More

#Exclusive Content

FDA
#Bluebird Bio #Cell and gene therapy #CRISPR #CRISPR Therapeutics #FDA #Sickle cell disorder (SCD) #Vertex

FDA approves gene therapies for sickle cell disease (with a warning)

The US Food and Drug Administration (FDA) has approved the first cell-based gene therapies for the treatment of sickle cell disease (SCD), Casgevy and Lyfgenia. Casgevy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is also the first FDA-approved treatment to use CRISPR gene editing technology. However, the FDA added a black… Read More

#News #Regulatory #Trending News

#Artificial intelligence (AI) #Cell and gene therapy #Drug discovery #Generative AI

Can vertical AI advance cell and gene therapies? 

Andrew Busey, Co-Founder, Form Bio, discusses why vertical AI is set to reshape the cell and gene therapy sector. The once-fictional artificial intelligence (AI) depicted in literature and movies has transitioned into a tangible and easily accessible tool in our modern world. General AI tools such as ChatGPT have acted… Read More

#Exclusive Content

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

DDW eBook: The latest innovations in cell and gene therapy

Hailed as a revolution in the treatment of many diseases, cell and gene therapy is the fastest growing area of therapeutics. This eBook, ‘Cell & Gene Therapy: The advances and innovation’, provides a comprehensive overview of the latest innovations in cell and gene therapies, where the… Read More

#News

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

Cell & Gene Therapy: The advances and innovation

This 24-page eBook sponsored by Sartorius explores the latest innovations in cell and gene therapies, where the challenges lie and the possible solutions to overcoming these obstacles. Download this free resource to learn more about: The ways cell and gene therapies (CGTs) are revolutionising medicine in a range of diseases How… Read More

#DDW eBooks #Intelligence

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

New DDW Highlights podcast: 20 November 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The breaking news this week was certainly the first regulatory approval for… Read More

#News

#CAR-T #Cell and gene therapy #Cell therapy #CRISPR #Drug discovery #Gene therapy

This week in drug discovery (13-17 November) 

News round-up for 13-17 November by DDW Digital Content Editor Diana Spencer. The breaking news this week was certainly the first regulatory approval for Casgevy, not only the first gene therapy approved for sickle cell disease, but also the first therapy to use CRISPR gene editing. Read More

#News

AAV virus
#Cell and gene therapy #Mouse models

How to advance AAV-based gene therapies

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies.   Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas. We’re beginning to see their… Read More

#Exclusive Content